(Q38484380)

3 September 2017

1 reference

title

New research on anxiety disorders in the elderly and an update on evidence-based treatments (English)

1 reference

3 September 2017

Carmen Andreescu

1

1 reference

3 September 2017

Daniel Varon

series ordinal

2

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 July 2015

1 reference

Current Psychiatry Reports

3 September 2017

1 reference

3 September 2017

17

1 reference

3 September 2017

7

1 reference

3 September 2017

53

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-015-0595-8

3 September 2017

0 references

cites work

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

The outcome of anxiety disorders in older people at 6-year follow-up: results from the Longitudinal Aging Study Amsterdam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

DSM-IV generalized anxiety disorder in the Australian National Survey of Mental Health and Well-Being.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

The prevalence of anxiety in older adults: methodological issues and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Prospective study of anxiety and incident stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

A review of the affects of worry and generalized anxiety disorder upon cardiovascular health and coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Risk factors for late-onset generalized anxiety disorder: results from a 12-year prospective cohort (the ESPRIT study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Deficient prefrontal attentional control in late-life generalized anxiety disorder: an fMRI investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

The relation of worry to prefrontal cortex volume in older adults with and without generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Altered cerebral blood flow patterns associated with pathologic worry in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Emotion reactivity and regulation in late-life generalized anxiety disorder: functional connectivity at baseline and post-treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Translational research in late-life mood disorders: implications for future intervention and prevention research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

The ages of anxiety--differences across the lifespan in the default mode network functional connectivity in generalized anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Inhibitory control and symptom severity in late life generalized anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Attentional bias in older adults: effects of generalized anxiety disorder and cognitive behavior therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Aging, emotional states, and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Divided attention in older but not younger adults is impaired by anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Cognitive impairment in late-life generalized anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Cognitive errors, symptom severity, and response to cognitive behavior therapy in older adults with generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Old worries and new anxieties: behavioral symptoms and mild cognitive impairment in a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Predictors of progression from mild cognitive impairment to Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

A questionnaire investigation of anxiety and depression in early dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Neural structures, functioning and connectivity in Generalized Anxiety Disorder and interaction with neuroendocrine systems: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Correlation between cortisol level and serotonin uptake in patients with chronic stress and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Decreased hypothalamus volumes in generalized anxiety disorder but not in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Basal hypothalamic pituitary adrenal axis activity and hippocampal volumes: the SMART-Medea study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

The brain and the stress axis: the neural correlates of cortisol regulation in response to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Amygdala and ventromedial prefrontal cortex are inversely coupled during regulation of negative affect and predict the diurnal pattern of cortisol secretion among older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Bringing the bedside to the bench, and then to the community: a prospectus for intervention research in late-life anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Anxiety disorders and salivary cortisol levels in older adults: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Regulation of hypothalamic-pituitary-adrenal activity in response to cognitive therapy in patients with generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

The critical role of clinical pharmacology in geriatric psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

A randomized, controlled trial of the effectiveness of cognitive-behavioral therapy and sertraline versus a waitlist control group for anxiety disorders in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Randomized, single-blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Paroxetine-induced hyponatremia in older adults: a 12-week prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Benzodiazepine use and physical disability in community-dwelling older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: a survey of 796 outpatients in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

A literature review of quetiapine for generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Risperidone for resistant anxiety in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

New possibilities of treatment for panic attacks in elderly patients: escitalopram versus citalopram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Efficacy of sertraline for panic disorder in older adults: a preliminary open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Treatment of anxiety disorders in older adults: a meta-analytic comparison of behavioral and pharmacological interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Cognitive-behavioral treatment of late-life generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Psychosocial treatment of late-life generalized anxiety disorder: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Meta-analysis comparing different behavioral treatments for late-life anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

The role of executive functioning in CBT: a pilot study with anxious older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Executive skills in older adults with GAD: relations with clinical variables and CBT outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Augmenting antidepressant medication with modular CBT for geriatric generalized anxiety disorder: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Mindfulness-based stress reduction for older adults with worry symptoms and co-occurring cognitive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Acceptance and Commitment Therapy for generalized anxiety disorder in older adults: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

Evidence-based pharmacotherapy of Generalized Anxiety Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

A randomized trial of the effectiveness of cognitive-behavioral therapy and supportive counseling for anxiety symptoms in older adults.

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11920-015-0595-8

21 January 2018

12 December 2020

Epidemiology and comorbidity of anxiety disorders in later life: implications for treatment.

1 reference

12 December 2020

Generalized anxiety in community-dwelling elderly: Prevalence and clinical characteristics.

1 reference

12 December 2020

Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients.

1 reference

12 December 2020

Treatment of generalized anxiety disorder in older adults

1 reference

12 December 2020

The relationship of age, anxiety, and serum immunoglobulins with crystallized and fluid intelligence.

1 reference

12 December 2020

Generalized anxiety disorder: nature and course

1 reference

12 December 2020

Age at onset of generalized anxiety disorder in older adults.

1 reference

12 December 2020

Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy.

1 reference

12 December 2020

10.1007/S11920-015-0595-8

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference